Research Topics
| Aljosa KandusSummaryAffiliation: University Medical Centre Country: Slovenia Publications
|
Detail Information
Publications
Effective immunoprophylaxis with basiliximab plus triple therapy in renal transplantation: five-year single-center experienceA Kandus
University Medical Center, Department of Nephrology, Ljubljana, Slovenia
Transplant Proc 38:2853-5. 2006....
Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized studyAljosa Kandus
Department of Nephrology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Transplantation 89:1022-7. 2010..In this prospective, randomized, open-label, single-center study, we compared the efficacy and safety of two anti-interleukin-2 receptor monoclonal antibodies combined with triple immunosuppression...- Survey of renal transplantation in SloveniaAljosa Kandus
Department of Nephrology, University Medical Center Ljubljana, SI 1000 Ljubljana, Slovenia
Ther Apher Dial 13:264-7. 2009..In 2004 we reached the average number of deceased donor renal transplants per million population of ET. Short- and medium-term results of the last nine-year period have been very good and entirely comparable to those in large reports... - Renal transplantation in Slovenia after joining EurotransplantAljosa Kandus
University Medical Centre Ljubljana, Department of Nephrology, Zaloska 7, 1000 Ljubljana, Slovenia
Nephrol Dial Transplant 21:36-9. 2006..This report presents data on renal transplantation in Slovenia before and after joining Eurotransplant (ET)... - Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipientsAljosa Kandus
Department of Nephrology, University Medical Center Ljubljana, University of Ljubljana, Slovenia
Ther Apher Dial 9:262-4. 2005.... - Treatment of anemia with epoetin in kidney transplant recipientsAndrej Bren
Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia
Ther Apher Dial 15:257-60. 2011..We concluded that the prevalence of renal anemia in kidney transplant recipients treated with epoetin was approximately 20%, and laboratory parameters suggested that the treatment of renal anemia in this study cohort was optimal... - Epoetin responsiveness in peritoneal dialysis patients: a multi-center Slovenian studyJernej Pajek
Department of Nephrology, University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia
Ther Apher Dial 9:228-32. 2005..Our results show that systemic inflammation, secondary hyperparathyroidism and angiotensin system antagonist treatment are the most important modifiable parameters affecting epoetin requirements in stable peritoneal dialysis patients... - Dialysis patients refusing kidney transplantation: data from the Slovenian Renal Replacement Therapy RegistryJadranka Buturovic-Ponikvar
Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia
Ther Apher Dial 15:245-9. 2011..Compared to the kidney transplant candidates, they are similar in age, gender and prevalence of diabetes. Patients treated by peritoneal dialysis refuse kidney transplantation less often than hemodialysis patients... - Dialysis patients after kidney graft failure: Slovenian experienceJakob Gubensek
Slovenian Renal Replacement Therapy Registry, Department of Nephrology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Ther Apher Dial 15:240-4. 2011..Studies focusing on the early period after graft failure are necessary to improve outcomes... - Association of pretransplant renal replacement therapy duration with outcome in kidney transplant recipients: a prevalent cohort study in SloveniaMiha Arnol
Department of Nephrology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Ther Apher Dial 15:234-9. 2011..This study suggests that a longer RRT duration negatively impacts on post-transplant patient and graft survival; however, when pretransplant patient survival is accounted for, RRT duration has no significant effect on patient outcome... - Slovenian renal replacement therapy registry: excerpts from the 2006 annual reportJadranka Buturovic-Ponikvar
Department of Nephrology, University Medical Center Ljubljana, SI 1000 Ljubljana, Slovenia
Ther Apher Dial 13:258-63. 2009..7%, of transplant recipients 1.35%, of both dialysis and transplant patients 11.4%. The number of patients positive for hepatitis B or C viruses is stable and low at 2.3% of the dialysis patients... - Our experience with epoetins in treating renal anemiaAndrej Bren
Department of Nephrology, University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia
Ther Apher Dial 9:202-4. 2005..Epoetin alpha, epoetin beta and epoetin omega seemed to be effective and safe in the treatment of renal anemia. In the past 2 years, epoetins were administered to hemodialysis patients only intravenously... - A comparison between epoetin omega and epoetin alfa in the correction of anemia in hemodialysis patients: a prospective, controlled crossover studyAndrej Bren
Department of Nephrology, University Medical Center, Ljubljana, Zaloska 7, 1525 Ljublijana, Slovenia
Artif Organs 26:91-7. 2002..The authors believe that additional comparisons of different epoetin preparations should be performed and will provide better insight into their biological activity and clinical responsiveness...